TEAD1-CD47 Fusion FISH Probe
The TEAD1-CD47 Fusion FISH Probe is used to confirm a fusion of the TEAD1 and CD47 genes. The fusion of the TEAD1 and CD47 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TEAD1-CD47-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TEAD1-CD47-20-AQAQ | 20 (40 μL) | 200 μL |
|
CD47 Gene Summary
This gene encodes a membrane protein, which is involved in the increase in intracellular calcium concentration that occurs upon cell adhesion to extracellular matrix. The encoded protein is also a receptor for the C-terminal cell binding domain of thrombospondin, and it may play a role in membrane transport and signal transduction. This gene has broad tissue distribution, and is reduced in expression on Rh erythrocytes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2010]
Gene Name: CD47 Molecule
Chromosome: CHR3: 107761940 -107809935
Locus: 3q13.12
TEAD1 Gene Summary
This gene encodes a ubiquitous transcriptional enhancer factor that is a member of the TEA/ATTS domain family. This protein directs the transactivation of a wide variety of genes and, in placental cells, also acts as a transcriptional repressor. Mutations in this gene cause Sveinsson's chorioretinal atrophy. Additional transcript variants have been described but their full-length natures have not been experimentally verified. [provided by RefSeq, May 2010]
Gene Name: TEA Domain Transcription Factor 1
Chromosome: CHR11: 12695968 -12966284
Locus: 11p15.3
Gene Diseases
The TEAD1 CD47 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|